Scientific Institute for Quality of Healthcare (IQ Healthcare), Radboud Institute for Health Science (RIHS), Radboud University Medical Center Nijmegen, PO Box 9101, Nijmegen, 6500, HB, The Netherlands.
Department of Medical Oncology, Radboud Institute for Health Science (RIHS), Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands.
J Cancer Surviv. 2021 Feb;15(1):163-177. doi: 10.1007/s11764-020-00921-8. Epub 2020 Sep 28.
To tailor implementation strategies that maximize adherence to physical cancer rehabilitation (PCR) guidelines, greater knowledge concerning determinants of adherence to those guidelines is needed. To this end, we assessed the determinants of adherence to PCR guidelines in the patient and cancer center.
We investigated adherence variation of PCR guideline-based indicators regarding [1] screening with the Distress Thermometer (DT), [2] information provision concerning physical activity (PA) and physical cancer rehabilitation programs (PCRPs), [3] advice to take part in PA and PCRPs, [4] referral to PCRPs, [5] participation in PCRPs, and [6] PA uptake (PAU) in nine cancer centers. Furthermore, we assessed patient and cancer center characteristics as possible determinants of adherence. Regression analyses were used to determine associations between guideline adherence and patient and cancer center characteristics. In these analyses, we assumed the patient (level 1) nested within the cancer center (level 2).
Nine hundred and ninety-nine patients diagnosed with cancer between January 2014 and June 2015 were included. Of the 999 patients included in the study, 468 (47%) received screening with the DT and 427 (44%) received information provision concerning PA and PCRPs. Subsequently, 550 (56%) patients were advised to take part in PA and PCRPs, which resulted in 174 (18%) official referrals. Ultimately, 280 (29%) patients participated in PCRPs, and 446 (45%) started PAU. Screening with the DT was significantly associated with information provision concerning PA and PCRPs (OR 1.99, 95% CI 1.47-2.71), advice to take part in PA and PCRPs (OR 1.79, 95% CI 1.31-2.45), referral to PCRPs (OR 1.81, 95% CI 1.18-2.78), participation in PCRPs (OR 2.04, 95% CI 1.43-2.91), and PAU (OR 1.69, 95% CI 1.25-2.29). Younger age, male gender, breast cancer as the tumor type, ≥2 cancer treatments, post-cancer treatment weight gain/loss, employment, and fatigue were determinants of guideline adherence. Less variation in scores of the indicators between the different cancer centers was found. This variation between centers was too low to detect any association between center characteristics with the indicators.
The implementation of PCR guidelines is in need of improvement. We found determinants at the patient level associated with guideline-based PCR care.
Implementation strategies that deal with the determinants of adherence to PCR guidelines might improve the implementation of PCR guidelines and the quality of life of cancer survivors.
为了制定最大程度提高物理癌症康复(PCR)指南依从性的实施策略,我们需要更多关于这些指南依从性决定因素的知识。为此,我们评估了患者和癌症中心对 PCR 指南依从性的决定因素。
我们调查了基于 PCR 指南的指标的依从性变化,这些指标包括[1]使用焦虑量表(DT)进行筛查,[2]提供有关身体活动(PA)和物理癌症康复计划(PCRP)的信息,[3]建议参加 PA 和 PCRP,[4]转诊至 PCRP,[5]参加 PCRP,以及[6]PA 参与度(PAU)。此外,我们评估了患者和癌症中心特征作为可能的依从性决定因素。回归分析用于确定指南依从性与患者和癌症中心特征之间的关联。在这些分析中,我们假设患者(第 1 级)嵌套在癌症中心(第 2 级)中。
纳入了 2014 年 1 月至 2015 年 6 月间被诊断患有癌症的 999 名患者。在纳入研究的 999 名患者中,468 名(47%)接受了 DT 筛查,427 名(44%)接受了有关 PA 和 PCRP 的信息提供。随后,550 名(56%)患者被建议参加 PA 和 PCRP,导致 174 名(18%)正式转诊。最终,280 名(29%)患者参加了 PCRP,446 名(45%)开始了 PAU。DT 筛查与 PA 和 PCRP 信息提供显著相关(OR 1.99,95%CI 1.47-2.71),建议参加 PA 和 PCRP(OR 1.79,95%CI 1.31-2.45),转诊至 PCRP(OR 1.81,95%CI 1.18-2.78),参加 PCRP(OR 2.04,95%CI 1.43-2.91),以及 PAU(OR 1.69,95%CI 1.25-2.29)。年轻、男性、乳腺癌为肿瘤类型、≥2 种癌症治疗、癌症治疗后体重增减、就业和疲劳是指南依从性的决定因素。不同癌症中心之间的指标评分变化较小。中心之间的这种变化太低,无法检测到中心特征与指标之间的任何关联。
PCR 指南的实施需要改进。我们发现了与基于指南的 PCR 护理依从性相关的患者层面的决定因素。
针对 PCR 指南依从性决定因素的实施策略可能会改善 PCR 指南的实施和癌症幸存者的生活质量。